Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Study Finds Possible Genetic Indicator of Colorectal Cancer

If perfected, screening method could make disease detection easier, experts say

By Randy Dotinga
HealthDay Reporter


Related Encyclopedia
 border=
Abdominoplasty
Acidophilus
Adenocarcinoma of the Lung and Brain Metastases
Adhesions
More...

Related Healthscout Videos
 border=
Optimistic Healing
Cancer Treatment for Any Size
Fever Kills Cancer
Cancer Detection
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
GERD
PPI Therapy
More...

Related Drug Information
 border=
Aciphex
Epogen
Iressa
Nexium
More...

Related News Articles
 border=
Vitamin D Deficiency Linked to Cardiovascular Disease
Low Vitamin D Tied to Estrogen Decline
Hormone Therapy & Breast Cancer
Developmental Delays Linked to Nicotine Gene?
More...

THURSDAY, June 18 (HealthDay News) -- Scientists say they may be moving closer to developing a genetic test for colorectal cancer that could indicate who needs a more advanced colonoscopy screening.

In a study released this week, an international team of researchers report that they've found a genetic red flag that indicates the presence of cancer more than half the time.

Text Continues Below



The research is in its preliminary stages. But "molecular genetics will likely be the future of colon cancer screening," predicted cancer specialist Dr. Jerald Wishner.

The American Cancer Society estimates that 106,100 new cases of colon cancer and 40,870 cases of rectal cancer are diagnosed in the United States each year. Nearly 50,000 people are expected to die of the diseases this year.

The death rate has been dropping over the past two decades, possibly as a result of better screening. But colonoscopies, which look for suspicious polyps, often miss tumors.

Among other things, colonoscopies might not detect small polyps, and their success depends on the skill of the person performing the procedure, said Wishner, director of the colorectal cancer program at Northern Westchester Hospital in Mount Kisco, N.Y.

There are other challenges. The cost convinces some people to avoid colonoscopies, and there aren't enough gastroenterologists to perform all that are necessary, said Dr. Scott Kopetz, an assistant professor in the Department of Gastrointestinal Medical Oncology at the University of Texas M.D. Anderson Cancer Center.

And, he said, people also avoid colonoscopies because of the inconvenience and discomfort.

Enter the idea of genetic screening, which could make colorectal cancer easier to detect by finding signs of the disease in the body's cells.

In the new study, published online June 17 in the Journal of the National Cancer Institute, researchers in the Netherlands, Belgium and the United States looked for genetic signs that appeared in cancerous colorectal cells and tissue but not in those from healthy people.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 6/18/2009

Related Links
 border=
From Healthscout's partner site on acid reflux, AcidRefluxConnection.com
SYMPTOMS: Learn about the symptoms of acid reflux disease
DRUGS: Common medications used to treat heartburn
TREATMENT: Lifestyle changes, medication, and surgeryoptions





SOURCES: Jerald Wishner, M.D., director, colorectal cancer program and colorectal surgery, Northern Westchester Hospital, Mount Kisco, N.Y.; Scott Kopetz, M.D., assistant professor, Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston; Gad Rennert, M.D., Ph.D., director, CHS National Israeli Cancer Control Center, Haifa, Israel; June 17, 2009, Journal of the National Cancer Institute


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy